MedTrace Logo

A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis

NCT00655109 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-04-09

No results posted yet for this study

Summary

To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis

Conditions

  • Conjunctivitis, Allergic

Interventions

DRUG

Olopatadine

Ophthalmic solution

DRUG

Fluticasone

Nasal spray

DRUG

Saline

Nasal spray

DRUG

Artificial tears

Ophthalmic Solution

Sponsors & Collaborators

  • Greiner, Jack V., OD DO PhD

    lead INDIV

Principal Investigators

  • Jack V Greiner, OD, DO, PhD · ORA, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00655109 on ClinicalTrials.gov